The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal? | Zendy

Panagiotis Theofilis | Zendy; Aikaterini Vordoni | Zendy; Rigas Kalaitzidis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?

Author(s) -

Panagiotis Theofilis,

Aikaterini Vordoni,

Rigas Kalaitzidis

Publication year - 2022

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000525441

Subject(s) - melatonin , medicine , endocrinology , insulin resistance , kidney disease , type 2 diabetes , diabetes mellitus , pathophysiology of hypertension , pineal gland , blood pressure

The increasing incidence of chronic kidney disease (CKD), as a consequence of the high prevalence of arterial hypertension and type 2 diabetes mellitus (T2DM), warrants the need for developing effective treatment approaches. In this regard, the pineal gland-derived hormone melatonin may represent an appealing treatment approach of CKD and its associated risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research